A Randomized, Open-Label Study Comparing the Effectiveness of Olanzapine Pamoate Depot with Haloperidol Decanoate in the Treatment of Schizophrenia.
Phase of Trial: Phase IV
Latest Information Update: 22 May 2014
At a glance
- Drugs Olanzapine (Primary) ; Haloperidol decanoate
- Indications Schizophrenia
- Focus Therapeutic Use
- Sponsors Eli Lilly
- 18 Aug 2011 This trial is recruiting in France and has discontinued in Hungary and United Kingdom.
- 18 Aug 2011 New trial record